|
|
|
Press Release: Eighth Asia Pacific Pharmaceutical and Medical Device Compliance Congress Features Update on the Revised IFPMA Code, the APEC Code and Other Pharma and Med Device Global Codes
|
- Sponsored by Asia Pacific Healthcare Industry Compliance Team
- Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
- September 10 - 12, 2018
- Shangri-La Hotel, Singapore
- www.AsianPharmaCongress.com
PRESS RELEASE
Phone: 800-503-6498
Email: registration@hcconferences.com
Website: www.AsianPharmaCongress.com |
EARLY BIRD REGISTRATION
- SAVE UP TO $300 -
|
Register by August 17, 2018 and save up to $300.
Click here to register.
|
|
|
FEATURING IFPMA, APEC AND OTHER PHARMA AND DEVICE GLOBAL COMPLIANCE CODES UPDATES BY
|
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore
|
|
Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma, Chair, IFPMA Code Capacity Workgroup, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
|
|
Ti Hwei How, MBA
Country President, AstraZeneca, President, Singapore Association of Pharmaceutical Industries, Co-chair, Healthcare Committee, European Chamber of Commerce in Singapore (EuroCham), Singapore
|
|
Chrisoula Nikidis
Canadian Head of Compliance and Ethics Solutions, IQVIA, Former Executive Director, Ethics and Compliance, Innovative Medicines Canada, Former Industry Co-Chair Designate, APEC Biopharmaceutical Working Group on Ethics, Ottawa, Canada
|
|
Geeta Thakerar
Legal and Compliance Consultancy Professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore
|
|
|
SINGAPORE -- PHARMA UPDATE NEWS SERVICE™ -- JULY 31, 2018: The Eighth Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 10 - 12, 2018 at the Shangri-La Hotel in Singapore.
|
|
KEYNOTE SPEAKERS
|
J. Neil Bearden, MBA, PhD
Associate Professor of Decision Sciences, INSEAD Singapore, Co-director, INSEAD Leadership, Programme for Senior Executives, Singapore |
Giovanni Buttarelli
European Data Protection Supervisor, Former Secretary General, Italian Data Protection Authority, Brussels, Belgium |
Charles Cain, JD
Chief, FCPA Unit, US Securities and Exchange Commission (SEC), Washington, DC, USA
|
Rachel Cooper, LLB, MSc
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, Former Director Global Health, Royal College of Obstetricians and Gynaecologists, Former Head, Government Relations, World Vision UK, Former Vice Consul, British Embassy, Copenhagen, Deputy Head of Mission, British Embassy, Bratislava, Deputy High Commissioner, Freetown, London, UK |
Abhiroop Gandhi, MS, MBA
Head of Strategic Risk Management, Trust & Compliance Lead, Verily (Google Life Sciences), Former Principal, Insights Life Science, Former Vice President, Corporate Compliance, Mallinckrodt, Former Executive Director, Compliance, Questcor, Former Director, Commercial Compliance, Actelion, San Francisco, CA, USA |
Tarek Helou, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC, USA
|
Ti Hwei How, MBA
Country President, AstraZeneca, President, Singapore Association of Pharmaceutical Industries, Co-chair, Healthcare Committee, European Chamber of Commerce in Singapore (EuroCham), Singapore |
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
|
|
|
FEATURING A HALF-DAY PRECONFERENCE SESSION ON
|
- Compliance and Ethical Issues in Patient Access and Support Programs and Activities with Patients and Patient Advocacy Organizations
|
|
PLENARY SESSIONS
|
- Welcome and Recognition of the Role of Ethics and Compliance
- Transparency International Update
- Update on the Revised IFPMA Code, the APEC Code and Other Global Codes
- The Regulation of Direct Sponsorships in the Asia Pac Region
- Asia Pac Hot Compliance Markets Updates: China, Indonesia, Korea, Malaysia and Vietnam
- Talk About Ethics is Confused by the Word "Ethics"
- Annual Leading Compliance Officer Roundtable
- GDPR Privacy Compliance Update
- US DOJ and SEC FCPA Enforcement Update
- Results of the 2018 Deloitte Asia Pac Life Science Compliance Survey
- Annual Asia Pac Anticorruption Roundtable
- The Patients' Perspective on Relationships with Pharma and Med Device Companies
- Strategies to Resolve Potential Conflicts of Interest
- The Emerging Role of Technology Companies in the Life Science Marketplace
- The Continued Evolution of Compliance as a Profession
|
|
|
|
AND MINI SUMMITS
|
- Third Party (Distributor, Vendor, Alliance Partner, Government-related Associations, HCOs, etc.) Management, including Pre-evaluation, Due Diligence, Contracting, Monitoring and Payment
- Annual Medical Device Compliance Roundtable
- Compliance Innovation
- Practical Approaches to Handling Investigations: Pre-investigation Preparations
- Chinese Anticorruption and Compliance Best Practices Roundtable
- Transparency Reporting Challenges and Approaches: Global Experience and Transparency Reporting in Asia
- Practical Approaches to Handling Investigations: The Investigation
- Data Privacy Updates: Impact of the GDPR and other Data Security Laws in Asia
- Using Data Analytics for Enhanced Compliance Monitoring
- Update on Drug Pricing Reductions and Control in the US
- The Future of Pharma-Private Insurance Collaborations in Asia Pac
- Practical Approaches to Handling Investigations: Gaining Information from Human Sources
- Best Practice in HCP/HCO Management
- The Role of the Compliance Officer in Cybersecurity
- Roundtable on Practical Approaches to Handling Investigations
|
|
|
FEATURED FACULTY
|
Ann Beasley, JD
Director, Life Sciences Regulatory & Compliance, Navigant Consulting, Inc.; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Co-chair, International Pharmaceutical and Medical Device Compliance Congress, Boston, MA, USA |
Uma Bhatt, PhD
Director, Technology Solutions, APAC, IQVIA; Former Senior Manager, Biostatistics and Data Operations, Daiichi Sankyo, Singapore |
Brian Caster, JD
Senior Director, Global Compliance Investigations, APAC Region, Pfizer, Tokyo, Japan
|
Stacy Chai
Partner, Fraud Investigation & Dispute Services, EY, Singapore |
Praween Chantanakomes, JD
Associate, Baker & McKenzie, Bangkok, Thailand |
Nitin Chhatwani, MA, MBA
Global Monitoring & Compliance Officer, GE Healthcare, Singapore
|
Chi Chen, MS, CFE, CISA
Forensic Technology Partner, EY, Shanghai, China |
Eugene Chen, Esq.
Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China |
Kherk Ying Chew, LLB, LLM
Partner and Head, Intellectual Property and Dispute Resolution Practice Groups, Baker & McKenzie, Wong & Partners, Kuala Lumpur, Malaysia
|
Ken Chia
Principal and Member, Asia Pacific IT & Communications and Global Privacy Steering Committees, Baker & McKenzie, Wong & Leow, Singapore |
Yoo-Kyung (Karen) Choi, JD, LLM
Japan and Korea Compliance Lead, Pfizer, Seoul, South Korea |
Hwee Ping Chua, LLM
Associate Vice President, International Legal & Compliance - Asia Pacific, China & Japan, Merck, Former Regional Counsel, Asia Pacific, Bristol-Myers Squibb, Singapore
|
Justus Chua
Head of Legal and Compliance, South East Asia and South Korea, Boehringer Ingelheim, Former Regional Counsel, (Developing Markets), Reckitt Benckiser Pharmaceuticals, Singapore |
Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea |
Cahyani Endahayu
Partner, Baker McKenzie, Jakarta, Indonesia
|
Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma, Chair, IFPMA Code Capacity Workgroup, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
Giuseppe Falbo
EAMEA Regional Compliance Head (Russia/CIS, Indian sub-continent, MEA), Shire, Former Regional Compliance Director (Asia and Russia), Alcon Laboratories, Inc., Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, United Arab Emirates |
J. Mark Farrar, CPA, CFE, CFF
Managing Director, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA
|
Chris Fordham
Managing Partner, Asia Pacific Area, Fraud Investigation and Dispute Services, EY, Hong Kong |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA |
Ronald Goon
Senior Director, Business Practices & Compliance, Johnson & Johnson, Former Regional Regulatory Manager, Covance Asia-Pacific, Singapore
|
Mohit Grover
Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore |
Casey J. Horton, CFE
Director, Life Sciences Regulatory & Compliance, Navigant Consulting, Inc., Chicago, IL, USA |
Shinji Iizumi
Compliance Director, Ferring Pharmaceuticals, Tokyo, Japan
|
Vanessa Han Jun
Head of Compliance, China, Novo Nordisk, Shanghai, China |
Sasha Kalb, JD
Vice President Risk and Compliance, American Express Global Business Travel, Former Senior APAC Compliance Counsel, 3M, Former Regional Compliance Counsel, Avon, Hong Kong |
Catherine Healy Kanzler, JD
Executive Director, Global Compliance Operations, Compliance Department, Olympus Corporation of the Americas, Center Valley, PA, USA
|
Jasmine Karimi, LLB
Senior Director and Counsel, APAC, Illumina, Former President, Hong Kong Corporate Counsel Association, Singapore |
Kent Kedl, MA
Senior Partner, Control Risks, Former Vice President and General Manager, Technomic Asia, Shanghai, China |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
|
Benjamin Kwak, JD
Vice President, Compliance Officer & Senior Legal Counsel, Asia Pacific, Zimmer Biomet, Singapore |
Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China |
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Former Co-
chair, Asia Pac Pharma Compliance Congress, Singapore
|
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China |
Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA |
Albert van Maaren, MsC
Regional Compliance Officer Healthcare APAC, Group Compliance, Merck KGaA, Singapore
|
Sol Magaz, MBA
Senior Principal, IQVIA, Singapore |
Christine Ng
Head, Ethics & Compliance Officer, Greater China, GSK, Shanghai, China |
Chrisoula Nikidis
Canadian Head of Compliance and Ethics Solutions, IQVIA, Former Executive Director, Ethics and Compliance, Innovative Medicines Canada, Former Industry Co-Chair Designate, APEC Biopharmaceutical Working Group on Ethics, Ottawa, Canada
|
Bob Pointer
Learning and Development Specialist, Course Design and Delivery Partner, REL Alliance Singapore, Berry Hill, Gloucestershire, UK |
Vivian Robinson, Esq.
Partner, McGuireWoods LLP, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK |
Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, Southeast Asia and Taiwan, AstraZeneca Pharmaceuticals, Singapore
|
Chris Royal, MBA, CIMA
Vice President, Ethics and Compliance Officer, Asia Pacific and Japan Global Ethics & Compliance, GSK, Singapore |
Yee Chung Seck
Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam |
Carol Shi
Area Compliance Director, Asia and ANZ, Astrazeneca, Singapore
|
Haiyan Tang, JD, PhD
Partner, Paul Hastings, Former Acting Compliance Regional Director in China, Pfizer, Shanghai, China |
Geeta Thakerar
Legal and Compliance Consultancy Professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore |
Yuet Ming Tham, JD
Partner and Global Head of White Collar: Government Litigation & Investigations Group and Head of Asia Pacific Compliance and Investigations Group, Singapore, Hong Kong
|
John Tsai
Forensic Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China |
Mini vandePol, LLB
Attorney and Chair, Global Compliance and Investigations Group, Baker McKenzie, Hong Kong |
Emmanuel Vignal
Asia-Pacific Managing Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China
|
Jonathan Shun Wah, PCLL
Assistant General Counsel - Greater China & APAC (ex South Asia) Investigations Lead, Pfizer, Hong Kong |
Chae Sing Wong
Asia Compliance Director, AstraZeneca; Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd; Former Compliance Director, Asia, ANZ and Japan, Baxalta; Former Compliance Director Asia Area, AstraZeneca, Kuala Lumpur, Malaysia |
Joyce Wong
Managing Director, Polaris Asia-Pacific, Former General Manager, Eli Lilly Asia Inc., Hong Kong
|
Angela M. Xenakis, MBA, JD
Partner, Sidley Austin LLP, Singapore |
Anh Nguyen Xuan, MBA
Chief Compliance Officer, Vietnam and Indochina, Sanofi Aventis, Ho Chi Minh City, Vietnam
|
|
|
2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 - 16, 2018
Hotel Savoyen
Vienna, Austria
www.International PharmaCongress.com
|
|
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 - 12, 2018
Singapore
www.Asian PharmaCongress.com
|
|
NINETEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 - 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
CO CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore
Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
Maria "Maru" Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics; Former Compliance Director, Asia, Abbott Laboratories; Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
SPONSORED BY:
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
COSPONSORED BY:
|
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
|
|
REGISTRATION DISCOUNTS AVAILABLE TO
|
|
|
GRANTORS:
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNER:
|
|
|
CONTINUING EDUCATION CREDITS
|
Accounting Professionals: Approved for up to 18.3 NASBA CPE credits.
Attorneys: The Congress is currently pending approval to offer Pennsylvania MCLE credit.
Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.
Click here for more information.
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - São Paulo
2013 - Madrid
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
2017 - Lisbon
2018 - Vienna
|
|
|
|
|
